Quality of life following bone marrow transplantation: Findings from a multicentre study

M. A. Andrykowski, C. B. Greiner, E. M. Altmaier, T. G. Burish, J. H. Antin, R. Gingrich, C. McGarigle, P. J. Henslee-Downey

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Questionnaires assessing a range of quality of life (QOL) outcomes were completed by 200 adult bone marrow transplant (BMT) recipients from five BMT treatment centres. Respondents had undergone allogeneic (46%) or autologous BMT (54%) for a haematological malignancy and were disease free and at least 12 months post BMT (mean 43 months). Variability in post-BMT QOL was reported with deficits in physical, sexual and occupational functioning particularly likely. Allogeneic recipients reported poorer QOL than autologous recipients. Greater age at BMT, lower level of education and more advanced disease at BMT were consistent risk factors for poorer QOL. Contrary to previous research, evidence for improved functional status with the passage of time post BMT was obtained. Factors generally not associated with post-BMT QOL included disease diagnosis, dose of total body irradiation, presence of chronic graft-versus-host disease (GVHD), type of GVHD prophylaxis and extent of marrow graft match. In conclusion, while many BMT recipients reported normal QOL, the majority indicated that their QOL was compromised relative to premorbid status. Prospective, longitudinal research will be necessary to further identify risk factors for poor post-BMT QOL and identify the temporal trajectory of post-BMT QOL.

Original languageEnglish (US)
Pages (from-to)1322-1329
Number of pages8
JournalBritish journal of cancer
Volume71
Issue number6
DOIs
StatePublished - Jun 1995

Fingerprint

Bone Marrow Transplantation
Multicenter Studies
Bone Marrow
Quality of Life
Transplants
Graft vs Host Disease
Bone Marrow Diseases
Whole-Body Irradiation
Hematologic Neoplasms
Research
Education

Keywords

  • Adjustment
  • Bone marrow transplantation
  • Psychosocial
  • Quality of life

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Andrykowski, M. A., Greiner, C. B., Altmaier, E. M., Burish, T. G., Antin, J. H., Gingrich, R., ... Henslee-Downey, P. J. (1995). Quality of life following bone marrow transplantation: Findings from a multicentre study. British journal of cancer, 71(6), 1322-1329. https://doi.org/10.1038/bjc.1995.257

Quality of life following bone marrow transplantation : Findings from a multicentre study. / Andrykowski, M. A.; Greiner, C. B.; Altmaier, E. M.; Burish, T. G.; Antin, J. H.; Gingrich, R.; McGarigle, C.; Henslee-Downey, P. J.

In: British journal of cancer, Vol. 71, No. 6, 06.1995, p. 1322-1329.

Research output: Contribution to journalArticle

Andrykowski, MA, Greiner, CB, Altmaier, EM, Burish, TG, Antin, JH, Gingrich, R, McGarigle, C & Henslee-Downey, PJ 1995, 'Quality of life following bone marrow transplantation: Findings from a multicentre study', British journal of cancer, vol. 71, no. 6, pp. 1322-1329. https://doi.org/10.1038/bjc.1995.257
Andrykowski MA, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R et al. Quality of life following bone marrow transplantation: Findings from a multicentre study. British journal of cancer. 1995 Jun;71(6):1322-1329. https://doi.org/10.1038/bjc.1995.257
Andrykowski, M. A. ; Greiner, C. B. ; Altmaier, E. M. ; Burish, T. G. ; Antin, J. H. ; Gingrich, R. ; McGarigle, C. ; Henslee-Downey, P. J. / Quality of life following bone marrow transplantation : Findings from a multicentre study. In: British journal of cancer. 1995 ; Vol. 71, No. 6. pp. 1322-1329.
@article{cbf6995b0623401797ff29e9dbf08676,
title = "Quality of life following bone marrow transplantation: Findings from a multicentre study",
abstract = "Questionnaires assessing a range of quality of life (QOL) outcomes were completed by 200 adult bone marrow transplant (BMT) recipients from five BMT treatment centres. Respondents had undergone allogeneic (46{\%}) or autologous BMT (54{\%}) for a haematological malignancy and were disease free and at least 12 months post BMT (mean 43 months). Variability in post-BMT QOL was reported with deficits in physical, sexual and occupational functioning particularly likely. Allogeneic recipients reported poorer QOL than autologous recipients. Greater age at BMT, lower level of education and more advanced disease at BMT were consistent risk factors for poorer QOL. Contrary to previous research, evidence for improved functional status with the passage of time post BMT was obtained. Factors generally not associated with post-BMT QOL included disease diagnosis, dose of total body irradiation, presence of chronic graft-versus-host disease (GVHD), type of GVHD prophylaxis and extent of marrow graft match. In conclusion, while many BMT recipients reported normal QOL, the majority indicated that their QOL was compromised relative to premorbid status. Prospective, longitudinal research will be necessary to further identify risk factors for poor post-BMT QOL and identify the temporal trajectory of post-BMT QOL.",
keywords = "Adjustment, Bone marrow transplantation, Psychosocial, Quality of life",
author = "Andrykowski, {M. A.} and Greiner, {C. B.} and Altmaier, {E. M.} and Burish, {T. G.} and Antin, {J. H.} and R. Gingrich and C. McGarigle and Henslee-Downey, {P. J.}",
year = "1995",
month = "6",
doi = "10.1038/bjc.1995.257",
language = "English (US)",
volume = "71",
pages = "1322--1329",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Quality of life following bone marrow transplantation

T2 - Findings from a multicentre study

AU - Andrykowski, M. A.

AU - Greiner, C. B.

AU - Altmaier, E. M.

AU - Burish, T. G.

AU - Antin, J. H.

AU - Gingrich, R.

AU - McGarigle, C.

AU - Henslee-Downey, P. J.

PY - 1995/6

Y1 - 1995/6

N2 - Questionnaires assessing a range of quality of life (QOL) outcomes were completed by 200 adult bone marrow transplant (BMT) recipients from five BMT treatment centres. Respondents had undergone allogeneic (46%) or autologous BMT (54%) for a haematological malignancy and were disease free and at least 12 months post BMT (mean 43 months). Variability in post-BMT QOL was reported with deficits in physical, sexual and occupational functioning particularly likely. Allogeneic recipients reported poorer QOL than autologous recipients. Greater age at BMT, lower level of education and more advanced disease at BMT were consistent risk factors for poorer QOL. Contrary to previous research, evidence for improved functional status with the passage of time post BMT was obtained. Factors generally not associated with post-BMT QOL included disease diagnosis, dose of total body irradiation, presence of chronic graft-versus-host disease (GVHD), type of GVHD prophylaxis and extent of marrow graft match. In conclusion, while many BMT recipients reported normal QOL, the majority indicated that their QOL was compromised relative to premorbid status. Prospective, longitudinal research will be necessary to further identify risk factors for poor post-BMT QOL and identify the temporal trajectory of post-BMT QOL.

AB - Questionnaires assessing a range of quality of life (QOL) outcomes were completed by 200 adult bone marrow transplant (BMT) recipients from five BMT treatment centres. Respondents had undergone allogeneic (46%) or autologous BMT (54%) for a haematological malignancy and were disease free and at least 12 months post BMT (mean 43 months). Variability in post-BMT QOL was reported with deficits in physical, sexual and occupational functioning particularly likely. Allogeneic recipients reported poorer QOL than autologous recipients. Greater age at BMT, lower level of education and more advanced disease at BMT were consistent risk factors for poorer QOL. Contrary to previous research, evidence for improved functional status with the passage of time post BMT was obtained. Factors generally not associated with post-BMT QOL included disease diagnosis, dose of total body irradiation, presence of chronic graft-versus-host disease (GVHD), type of GVHD prophylaxis and extent of marrow graft match. In conclusion, while many BMT recipients reported normal QOL, the majority indicated that their QOL was compromised relative to premorbid status. Prospective, longitudinal research will be necessary to further identify risk factors for poor post-BMT QOL and identify the temporal trajectory of post-BMT QOL.

KW - Adjustment

KW - Bone marrow transplantation

KW - Psychosocial

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0029023363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029023363&partnerID=8YFLogxK

U2 - 10.1038/bjc.1995.257

DO - 10.1038/bjc.1995.257

M3 - Article

C2 - 7779732

AN - SCOPUS:0029023363

VL - 71

SP - 1322

EP - 1329

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -